PetIQ Inc. (PETQ) PT Raised to $41 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019 4:05 PM EDTFourth Quarter 2018 Net Sales Increased 114% Year-Over-Year to $111.0 Million Full Year 2018 Net Sales of $528.6 Million Provides Full Year 2019 Outlook
EAGLE, Idaho, March 11, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights Compared to Prior Year Period
Record fourth quarter net sales of $111.0 million, an increase of 114%;Â representing organic net sales growth of 70%Net loss of... More